Neonatal alloimmune thrombocytopenia.
作者信息
Rayment R, Birchall J, Yarranton H, Hewertson J, Allen D, Murphy M F, Roberts D J
机构信息
National Blood Service, John Radcliffe Hospital, Oxford OX3 9DU.
出版信息
BMJ. 2003 Aug 9;327(7410):331-2. doi: 10.1136/bmj.327.7410.331.
Abstract
摘要
相似文献
1
Neonatal alloimmune thrombocytopenia.新生儿同种免疫性血小板减少症
BMJ. 2003 Aug 9;327(7410):331-2. doi: 10.1136/bmj.327.7410.331.
2
What's happening? The expanding role of apheresis platelet support in neonatal alloimmune thrombocytopenia: current status and future trends.发生了什么？单采血小板支持在新生儿同种免疫性血小板减少症中的作用不断扩大：现状与未来趋势。
Transfus Apher Sci. 2005 Oct;33(2):191-7. doi: 10.1016/j.transci.2005.06.001.
3
Petechiae in a Newborn.新生儿瘀点
Am Fam Physician. 2015 Dec 1;92(11):1017-8.
4
The "platelet boilermaker": A treatment protocol to rapidly increase platelets in patients with immune-mediated thrombocytopenia.“血小板强力针剂”：一种快速提升免疫性血小板减少症患者血小板数量的治疗方案。
Am J Hematol. 2016 Aug;91(8):E330-1. doi: 10.1002/ajh.24409. Epub 2016 Jun 3.
5
[Neonatal autoimmune purpura: laboratory study of 5 cases].[新生儿自身免疫性紫癜：5例实验室研究]
Rev Med Chil. 1992 Aug;120(8):899-904.
6
Neonatal thrombocytopenia: causes and management.新生儿血小板减少症：病因与管理
Arch Dis Child Fetal Neonatal Ed. 2003 Sep;88(5):F359-64. doi: 10.1136/fn.88.5.f359.
7
Anti-HPA-3A induces severe neonatal alloimmune thrombocytopenia.抗HPA - 3A会引发严重的新生儿同种免疫性血小板减少症。
J Pediatr. 2001 Jun;138(6):862-7. doi: 10.1067/mpd.2001.114029.
8
Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.母体特发性血小板减少性紫癜导致新生儿血小板减少症的结局与处理。
Vox Sang. 2013 Oct;105(3):236-43. doi: 10.1111/vox.12036. Epub 2013 Jun 19.
9
[Neonatal alloimmune thrombocytopenic purpura caused by anti-HPA-1a alloantibodies. Case report].[抗HPA-1a同种抗体引起的新生儿同种免疫性血小板减少性紫癜。病例报告]
Lijec Vjesn. 2001 Mar-Apr;123(3-4):70-3.
10
HPA-1a(-), 5b(-) platelets for use in neonatal alloimmune thrombocytopenia--from 'Cinderella' product to standard component.
Transfus Med. 2014 Apr;24(2):127-9. doi: 10.1111/tme.12108.
引用本文的文献
1
A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology.一种基于肽适体技术的新型抗人血小板抗原抗体（HPA-1a）检测方法。
Haematologica. 2012 May;97(5):696-704. doi: 10.3324/haematol.2011.051276. Epub 2011 Dec 1.
2
Antenatal interventions for fetomaternal alloimmune thrombocytopenia.胎儿母体型同种免疫性血小板减少症的产前干预措施。
Cochrane Database Syst Rev. 2011 May 11(5):CD004226. doi: 10.1002/14651858.CD004226.pub3.
本文引用的文献
1
The management of alloimmune neonatal thrombocytopenia.新生儿同种免疫性血小板减少症的管理
Baillieres Best Pract Res Clin Haematol. 2000 Sep;13(3):365-90. doi: 10.1053/beha.2000.0083.
2
Management of severe alloimmune thrombocytopenia in the newborn.新生儿严重同种免疫性血小板减少症的管理
Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F173-5. doi: 10.1136/fn.82.3.f173.
3
Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT).胎儿母体外周免疫性血小板减少症（FMAIT）产后管理中的不足之处。
Br J Haematol. 1999 Apr;105(1):123-6.
4
5
Fetal thrombocytopenia and its relation to maternal thrombocytopenia.胎儿血小板减少症及其与母体血小板减少症的关系。
N Engl J Med. 1993 Nov 11;329(20):1463-6. doi: 10.1056/NEJM199311113292005.
6
Difficulties in the antenatal assessment of neonatal alloimmune thrombocytopenia.新生儿同种免疫性血小板减少症产前评估的困难
Acta Obstet Gynecol Scand. 1993 Oct;72(7):583-5. doi: 10.3109/00016349309058169.
7
Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia.对分娩有或无新生儿同种免疫性血小板减少症婴儿的同种免疫母亲的免疫球蛋白类别、IgG亚类及HPA-1a抗体滴度的分析。
Br J Haematol. 1994 Aug;87(4):813-7. doi: 10.1111/j.1365-2141.1994.tb06742.x.
8
348 cases of suspected neonatal alloimmune thrombocytopenia.348例疑似新生儿同种免疫性血小板减少症病例。
Lancet. 1989 Feb 18;1(8634):363-6. doi: 10.1016/s0140-6736(89)91733-9.
9
10
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen.
Hum Immunol. 1990 Feb;27(2):73-9. doi: 10.1016/0198-8859(90)90104-w.
Zotero 插件